Antiplatelet therapy: new pharmacological agents and changing paradigms von Capodanno, D., Ferreiro, J. L., Angiolillo, D. J.

Volltext

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Compa... von Angiolillo, D J, Gibson, C M, Cheng, S, Ollier, C, Nicolas, O, Bergougnan, L, Perrin, L, LaCreta, F P, Hurbin, F, Dubar, M

Volltext

Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation von Capra, V., Bäck, M., Angiolillo, D. J., Cattaneo, M., Sakariassen, K. S.

Volltext

Platelet thrombin receptor antagonism and atherothrombosis von Angiolillo, Dominick J., Capodanno, Davide, Goto, Shinya

Volltext

Findings of intravascular ultrasound during acute stent thrombosis von Alfonso, F, Suárez, A, Angiolillo, D J, Sabaté, M, Escaned, J, Moreno, R, Hernández, R, Bañuelos, C, Macaya, C

Volltext

Current concepts on coronary revascularization in diabetic patients von Roffi, Marco, Angiolillo, Dominick J., Kappetein, A. Pieter

Volltext

Safety and efficacy of protease‐activated receptor‐1 antagonists in patients with coronary artery disease: a meta‐analysis of randomized clinical trials von CAPODANNO, D., BHATT, D. L., GOTO, S., O’DONOGHUE, M. L., MOLITERNO, D. J., TAMBURINO, C., ANGIOLILLO, D. J.

Volltext

Variability in Responsiveness to Oral Antiplatelet Therapy von Angiolillo, Dominick J., MD, PhD

Volltext

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients von Erlinge, David, MD, PhD, ten Berg, Jurrien, MD, PhD, Foley, David, MD, Angiolillo, Dominick J., MD, PhD, Wagner, Henrik, MD, Brown, Patricia B., BSN, RN, Zhou, Chunmei, MS, Luo, Junxiang, PhD, Jakubowski, Joseph A., PhD, Moser, Brian, MS, Small, David S., PhD, Bergmeijer, Thomas, MD, James, Stefan, MD, PhD, Winters, Kenneth J., MD

Volltext

Detecting a thienopyridine effect by platelet reactivity assessment and its implications for risk stratification von Price, M. J., Baker, B. A., Jakubowski, J. A., Li, W., Heiselman, D. E., Angiolillo, D. J.

Volltext

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes von Schüpke, Stefanie, Neumann, Franz-Josef, Menichelli, Maurizio, Mayer, Katharina, Bernlochner, Isabell, Wöhrle, Jochen, Richardt, Gert, Liebetrau, Christoph, Witzenbichler, Bernhard, Antoniucci, David, Akin, Ibrahim, Bott-Flügel, Lorenz, Fischer, Marcus, Landmesser, Ulf, Katus, Hugo A, Sibbing, Dirk, Seyfarth, Melchior, Janisch, Marion, Boncompagni, Duino, Hilz, Raphaela, Rottbauer, Wolfgang, Okrojek, Rainer, Möllmann, Helge, Hochholzer, Willibald, Migliorini, Angela, Cassese, Salvatore, Mollo, Pasquale, Xhepa, Erion, Kufner, Sebastian, Strehle, Axel, Leggewie, Stefan, Allali, Abdelhakim, Ndrepepa, Gjin, Schühlen, Helmut, Angiolillo, Dominick J, Hamm, Christian W, Hapfelmeier, Alexander, Tölg, Ralph, Trenk, Dietmar, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Kastrati, Adnan

Volltext

Ticagrelor with or without Aspirin in High-Risk Patients after PCI von Mehran, Roxana, Baber, Usman, Sharma, Samin K, Cohen, David J, Angiolillo, Dominick J, Briguori, Carlo, Cha, Jin Y, Collier, Timothy, Dangas, George, Dudek, Dariusz, Džavík, Vladimír, Escaned, Javier, Gil, Robert, Gurbel, Paul, Hamm, Christian W, Henry, Timothy, Huber, Kurt, Kastrati, Adnan, Kaul, Upendra, Kornowski, Ran, Krucoff, Mitchell, Kunadian, Vijay, Marx, Steven O, Mehta, Shamir R, Moliterno, David, Ohman, E. Magnus, Oldroyd, Keith, Sardella, Gennaro, Sartori, Samantha, Shlofmitz, Richard, Steg, P. Gabriel, Weisz, Giora, Witzenbichler, Bernhard, Han, Ya-ling, Pocock, Stuart, Gibson, C. Michael

Volltext

Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial von Jiménez-Quevedo, Pilar, Sabaté, Manel, Angiolillo, Dominick J., Alfonso, Fernando, Hernández-Antolín, Rosana, SanMartín, Marcelo, Gómez-Hospital, Joan Antoni, Bañuelos, Camino, Escaned, Javier, Moreno, Raúl, Fernández, Cristina, Fernández-Avilés, Francisco, Macaya, Carlos

Volltext

Tackling the diabetic platelet: is high clopidogrel dosing the answer? von ANGIOLILLO, D. J.

Volltext

Mortality with bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome von Galli, M, Gargiulo, G, Benenati, S, Mehran, R, Angiolillo, D J

Volltext

Impact of race and gender on antithrombotic therapy von Capodanno, Davide, Angiolillo, Dominick J.

Volltext

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting von Schulz-Schüpke, Stefanie, Byrne, Robert A, Ten Berg, Jurrien M, Neumann, Franz-Josef, Han, Yaling, Adriaenssens, Tom, Tölg, Ralph, Seyfarth, Melchior, Maeng, Michael, Zrenner, Bernhard, Jacobshagen, Claudius, Mudra, Harald, von Hodenberg, Eberhard, Wöhrle, Jochen, Angiolillo, Dominick J, von Merzljak, Barbara, Rifatov, Nonglag, Kufner, Sebastian, Morath, Tanja, Feuchtenberger, Antonia, Ibrahim, Tareq, Janssen, Paul W A, Valina, Christian, Li, Yi, Desmet, Walter, Abdel-Wahab, Mohamed, Tiroch, Klaus, Hengstenberg, Christian, Bernlochner, Isabell, Fischer, Marcus, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Schömig, Albert, Mehilli, Julinda, Kastrati, Adnan

Volltext

Platelet function testing and risk of bleeding complications von Ferreiro, José Luis, Sibbing, Dirk, Angiolillo, Dominick J.

Volltext

Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic... von Cavender, Matthew A, Scirica, Benjamin M, Bonaca, Marc P, Angiolillo, Dominick J, Dalby, Anthony J, Dellborg, Mikael, Morais, Joao, Murphy, Sabina A, Ophuis, Ton Oude, Tendera, Michal, Braunwald, Eugene, Morrow, David A

Volltext

Antithrombotic Therapy in Patients With Chronic Kidney Disease von CAPODANNO, Davide, ANGIOLILLO, Dominick J

Volltext